COVID-19-Induced Hepatic Injury: A Systematic Review and Meta-Analysis
Internal Medicine
[키워드] 95% CI
abnormality
Alanine
alanine aminotransferase
albumin
albumin levels
ALT
analyzed
aspartate
Aspartate aminotransferase
AST
Biochemistry
Cohort studies
Complication
conducted
COVID-19
COVID-19 patients
COVID‐19 infection
critically ill patients
database
disease severity
dysfunction
Health
hepatic
hepatic injury
increases in
lfts
liver
liver enzyme
Liver injury
liver injury biomarkers
marker
material
mean difference
Meta-analysis
Newcastle-Ottawa Scale
non-severe cases
NOS
novel coronavirus disease
outcome
pandemic
Prognostic factor
Prospective Study
pulmonary
R statistical software
reported
Result
retrospective
review
risk of bia
SARS-CoV-2
searched
serum analysis
Serum level
Severe case
severe cases
severity of COVID-19
significantly higher
significantly lower
stratified
subgroup analysis
systematic review
systematic review and meta-analysis
total bilirubin
Web of Science
with COVID-19
[DOI] 10.7759/cureus.10923 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.10923 PMC 바로가기 [Article Type] Internal Medicine